PROTALIX BIOTHERAPEUTICS, INC. (PLX): Protalix BioTherapeutics – Consensus Ind...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

PROTALIX BIOTHERAPEUTICS, INC. (PLX)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	144
Posts	27605
Boards Moderated	3
Alias Born	02/07/2004

Re: None

Tuesday, 08/18/2020 5:37:10 AM

Tuesday, August 18, 2020 5:37:10 AM

Protalix BioTherapeutics – Consensus Indicates Potential 175.4% Upside

Article by: Amilia Stone 17th August 2020

Protalix BioTherapeutics with ticker code (PLX) have now 2 analysts in total covering the stock. The consensus rating is ‘Strong_Buy’. The range between the high target price and low target price is between 11 and 8.5 with the average target price sitting at 9.75. With the stocks previous close at 3.54 this indicates there is a potential upside of 175.4%. The 50 day MA is 3.63 while the 200 day moving average is 3.35. The company has a market capitalisation of $120m. Company Website: http://www.protalix.com

https://www.directorstalkinterviews.com/protalix-biotherapeutics-consensus-indicates-potential-175-4-upside/412851807

Protalix Biotherapeutics Inc (PLX) stock is up 52.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PLX stock a score of 86 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 93. PLX's rank also includes a fundamental score of 88. In addition to the average rating from Wall Street analysts, PLX stock has a mean target price of 9.75. This means analysts expect the stock to increase 151.94% over the next 12 months. The long-term technical score for PLX is 78.

https://www.investorsobserver.com/news/stock-update/protalix-biotherapeutics-inc-plx-stock-buy-hold-or-sell

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent PLX News

Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 09:05:17 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/17/2024 09:00:28 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 11:20:49 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 10:59:36 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/02/2024 11:36:07 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 11:56:21 AM
Levicept Appoints Eliot Forster as CEO • GlobeNewswire Inc. • 11/30/2023 09:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 12:50:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 12:22:32 PM
Upcoming Earnings Release Paired With Price Target Raise Sends Stock Soaring • AllPennyStocks.com • 10/31/2023 08:40:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 10:50:07 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 09:00:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 09:00:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 09:00:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 09:00:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:46:57 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:45:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 10:58:32 AM
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 09/06/2023 10:50:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:30:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:30:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:30:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:30:12 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/11/2023 08:31:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 11:02:19 AM

More PLX News

InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow